Leukocyte count, systemic inflammation, and health status in older adults: a narrative review
DOI:
https://doi.org/10.2478/anre-2018-0007Keywords:
aging, inflammation, leukocyte count, longevity, mortality, morbidity, senescenceAbstract
Epidemiological and clinical studies suggest that elevated leukocyte count within the normal range can predict cardiovascular and total mortality in older adults. These findings are remarkable because this simple and common laboratory test is included in routine medical check-ups. It is well known that chronic systemic inflammation (inflammaging) is one of the hallmarks of aging and an important component of obesity-associated insulin resistance that can lead to type 2 diabetes and other health problems in both overweight individuals and elderly people. To understand the molecular mechanisms linking increased systemic inflammation with aging-associated diseases and elevated leukocyte counts in the elderly is to unravel the multiplicity of molecular factors and mechanisms involved in chronic low-grade systemic inflammation, the gradual accumulation of random molecular damage, age-related diseases, and the process of leukopoiesis. There are several possible mechanisms through which chronic low-grade systemic inflammation is associated with both higher leukocyte count and a greater risk of aging-associated conditions in older adults. For example, the IL-6 centric model predicts that this biomediator is involved in chronic systemic inflammation and leukopoiesis, thereby suggesting that elevated leukocyte count is a signal of poor health in older adults. Alternatively, an increase in neutrophil and monocyte counts can be a direct cause of cardiovascular events in the elderly. Interestingly, some authors assert that the predictive ability of elevated leukocyte counts with regard to cardiovascular and allcause mortality among older adults surpass the predictive value of total cholesterol. This review reports the recent findings on the links between elevated but normal leukocyte counts and the increased risks of all-cause, cardiovascular, and cancer mortality. The possible molecular mechanisms linking higher but normal leukocyte counts with increased risk of aging-associated diseases in the elderly are discussed here.
Downloads
References
Aird KM, Zhang R. 2014. Metabolic alterations accompanying oncogene-induced senescence. Mol Cell Oncol 1:e963481.
Alexander RW. 1994. Inflammation and coronary artery disease. N Engl J Med, 331:468–9.
Arai Y, Martin-Ruiz CM, Takayama M, Abe Y, Takebayashi T, Koyasu S, Suematsu M, Hirose N, von Zglinicki T. 2015. Inflammation, but not telomere length, predicts successful ageing at extreme old age: A longitudinal study of semi-supercentenarians. EBioMedicine 2:1549–58.
Bauer ME, De la Fuente M. 2013. Oxidative stress, inflammaging, and immunosenescence. Inflamm Adv Age Nutr Res Clin Interv 74:39–47.
Bell JA, Kivimäki M, Bullmore ET, Steptoe A; MRC ImmunoPsychiatry Consortium, Carvalho LA. 2017. Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults. Transl Psychiatry 7:e1208.
Benca RM, Peterson MJ. 2008. Insomnia and depression. Sleep Med 9 Suppl 1:S3–9.
Beydoun MA, Beydoun HA, Dore GA, Canas J-A, Fanelli-Kuczmarski MT, Evans MK, Zonderman AB. 2016. White blood cell inflammatory markers are associated with depressive symptoms in a longitudinal study of urban adults. Transl Psychiatry 6:e895.
Bonomi M, Patsias A, Posner M, Sikora A. 2014. The role of inflammation in head and neck cancer. Adv Exp Med Biol 816:107–27.
Brito LB, Ricardo DR, Araújo DS, Ramos PS, Myers J, Araújo CG. 2014. Ability to sit and rise from the floor as a predictor of all-cause mortality. Eur J Prev Cardiol 21:892–8.
Brown DW, Giles WH, Croft JB. 2001. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54:316–22.
Bulterijs S, Hull RS, Björk VC, Roy AG. 2015. It is time to classify biological aging as a disease. Front Genet 6:205.
Carel RS, Eviatar J. 1985. Factors affecting leukocyte count in healthy adults. Prev Med 14:607–19.
Chang SS, Weiss CO, Xue QL, Fried LP. 2012. Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 54:9–15.
Childs BG, Durik M, Baker DJ, van Deursen JM. 2015. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424–35.
Chmielewski P, Borysławski K, Chmielowiec K, Chmielowiec J. 2015a. Height loss with advancing age in a hospitalized population of Polish men and women: magnitude, pattern and associations with mortality. Anthropol Rev 78:157–68.
Chmielewski P, Borysławski K, Chmielowiec K, Chmielowiec J. 2015b. Longitudinal and cross-sectional changes with age in selected anthropometric and physiological traits in hospitalized adults: and insight from the Polish Longitudinal Study of Aging (PLSA). Anthropol Rev 78:317–36.
Chmielewski P. 2016. Teoria sezonowego programowania długowieczności. Kosmos 65(3):323–37.
Chmielewski P, Borysławski K. 2016. Proksymalne przyczyny starzenia się człowieka: przypadkowe uszkodzenia molekularne czy hiperfunkcja programów rozwojowych? Kosmos 65(3):339–49.
Chmielewski P, Borysławski K, Strzelec B. 2016a. Contemporary views on human aging and longevity. Anthropol Rev 79:115–42.
Chmielewski PP, Borysławski K, Chmielowiec K, Chmielowiec J, Strzelec B. 2016b. The association between total leukocyte count and longevity: Evidence from longitudinal and cross-sectional data. Ann Anat 204:1–10.
Chmielewski P. 2017. Rethinking modern theories of ageing and their classification: the proximate mechanisms and the ultimate explanations. Anthropol Rev 80:259–72.
Chmielewski PP, Strzelec B. 2017. Elevated leukocyte count as a harbinger of systemic inflammation, disease progression, and poor prognosis: a review. Folia Morphol available at: https://journals.viamedica.pl/folia_morphologica
Christy RM, Baskurt OK, Gass GC, Gray AB, Marshall-Gradisnik SM. 2010. Erythrocyte aggregation and neutrophil function in an aging population. Gerontology 56:175–180.
Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860–7.
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56.
Dantzer R, Capuron L. 2017. Inflammation-associated depression: evidence, mechanisms and implications. New York: Springer.
De la Fuente M, Miquel J. 2009. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des 15:3003–26.
Ekström I, Sjölund S, Nordin S, Nordin Adolfsson A, Adolfsson R, Nilsson LG, Larsson M, Olofsson JK. 2017. Smell loss predicts mortality risk regardless of dementia conversion. J Am Geriatr Soc 65:1238–43.
Erlinger TP, Muntner P, Helzlsouer KJ. 2004. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev 13:1052–6.
Exp Gerontol 39:687–99.
Franceschi C, Campisi J. 2014. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69:S4–9.
Freund A, Orjalo AV, Desprez PY, Campisi J. 2010. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16:238–46.
Furman D, Chang J, Lartigue L, Bolen CR, Haddad F, Gaudilliere B, Ganio EA, Fragiadakis GK, Spitzer MH, Douchet I, Daburon S, Moreau JF, Nolan GP, Blanco P, Déchanet-Merville J, Dekker CL, Jojic V, Kuo CJ, Davis MM, Faustin B. 2017. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat Med 23:174–84.
Grimm RH Jr, Neaton JD, Ludwig W. 1985. Prognostic importance of the white blood cell count for coronary, cancer, and allcause mortality. JAMA 254:1932–7.
Gupta S, Maratha A, Gajanayake T, Siednienko J, Natarajan A, Hoashi S, Miggin S. 2011. Cytokine profiling of pre-diabetic patients. Endocrine Abstracts 25:119.
Hayflick L, Moorhead PS. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621.
Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614–36.
Hayflick L. 1993. Aspects of cellular aging. Reviews in Clinical Gerontology 3:207–22.
Hayflick L. 1994. How and why we age. New York: Ballantine Books.
Hayflick L. 2000. The future of ageing. Nature 408:267–9.
Hayflick L. 2007. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 1100:1-13.
Heppner FL, Ransohoff RM, Becher B. 2015. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358–72.
Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860–7.
Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, Augustine AD, McElhaney JE, Kohanski R, Sierra F. 2013. The role of inflammation in age-related disease. Aging 5:84–93.
Jenny NS. 2012. Inflammation in aging: cause, effect, or both? Disc Med 13:451–60.
Jeon SW, Kim YK. 2017. Inflammation-induced depression: Its pathophysiology and therapeutic implications. J Neuroimmunol 313:92–8.
Kabat GC, Kim MY, Manson JAE, Lessin L, Lin J, Wassertheil-Smoller S, Rohan TE. 2017. White blood cell count and total and cause-specific mortality in the Women’s Health Initiative. Am J Epidemiol 22:1–10.
Kahlem P, Dörken B, Schmitt CA. 2004. Cellular senescence in cancer treatment: friend or foe? J Clin Invest 113:169–74.
Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–6.
Karan MA, Cefle K, Tamer Ş, Erten N, Albenz I, Öztürk Ş, Palandüz Ş. 2005. Increased leukocyte rigidity in the elderly. Middle East Journal of Age and Ageing 3:1–5.
Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, Rando TA, Richardson A, Schadt EE, Wyss-Coray T, Sierra F. 2014. Geroscience: linking aging to chronic disease. Cell 159:709–13.
Kirkwood TB. 2005. Understanding the odd science of aging. Cell 120:437–47.
Kovács A, Szikszai Z, Várady E, Imre S. 2006. Study on the hemorheological parameters of oldest-old residents in the East-Hungarian city, Debrecen. Clin Hemorheol Micricirc 35:83–8.
Krabbe KS, Pedersen M, Bruunsgaard H. 2004. Inflammatory mediators in the elderly.
Kumar M, Babaei P, Ji B, Nielsen J. 2016. Human gut microbiota and health aging: Recent developments and future prospective. Nutr Healthy Aging 4:3–16.
Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. 2001. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154:758–64.
Leng SX, Xue QL, Huang Y, Ferrucci L, Fried LP, Walston JD. 2005a. Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Exp Gerontol 40:982–7.
Leng SX, Xue QL, Huang Y, Semba R, Chaves P, Bandeen-Roche K, Fried L, Walston J. 2005b.Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med 60:195–9.
Leng SX, Xue QL, Tian J, Huang Y, Yeh SH, Fried LP. 2009. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women’s Health and Aging Studies I. Exp Gerontol 44:511–6.
Libby P. 2006. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83:456S–60S.
Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R, Women’s Health Initiative Research Group. 2005. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med 165:500–8.
Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A. 2007. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med 167:1837–44.
Marioni RE, Ritchie SJ, Joshi PK, Hagenaars SP, Okbay A, Fischer K, Adams MJ, Hill WD, Davies G; Social Science Genetic Association Consortium, Nagy R, Amador C, Läll K, Metspalu A, Liewald DC, Campbell A, Wilson JF, Hayward C, Esko T, Porteous DJ, Gale CR, Deary IJ. 2016a. Genetic variants linked to education predict longevity. Proc Natl Acad Sci U S A 113:13366–71.
Marioni RE, Harris SE, Shah S, McRae AF, von Zglinicki T, Martin-Ruiz C, Wray NR, Visscher PM, Deary IJ. 2016b. The epigenetic clock and telomere length are independently associated with chronological age and mortality. Int J Epidemiol.
Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, Cohen P, Barzilai N. 2014. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13:769–71.
Nilsson G, Hedberg P, Öhrvik J. 2014. White blood cell count in elderly is clinically useful in predicting long-term survival. J Aging Res 2014:475093.
Polednak AP. 1978. Age changes in differential leukocyte count among female students. Hum Biol 50:301–11.
Rakoff-Nahoum S. 2006. Why cancer and inflammation? Yale J Biol Med 79:123–30.
Raman K, Chong M, Akhtar-Danesh GG, D’Mello M, Hasso R, Ross S, Xu F, Paré G. 2013. Genetic markers of inflammation and their role in cardiovascular disease. Can J Cardiol 29:67–74.
Rattan SIS. 2006. Theories of biological aging: genes, proteins, and free radicals. Free Radic Res 40:1230–8.
Rattan SIS. 2014. Aging is not a disease: Implications for interventions. Aging Dis 5:196–202.
Rattan SIS. 2016. If aging is a disease, then it is your own fault. J Aging Sci 4:2.
Rattan SIS. 2016. Origins of the Hayflick system, the phenomenon and the limit. In: SIS Rattan, L Hayflick, editors. Cellular ageing and replicative senescence. New York: Springer.
Reiss AB, Glass AD. 2006. Atherosclerosis: immune and inflammatory aspects. J Investig Med 54:123–31.
Ross R. 1999. Atherosclerosis – an inflammatory disease. N Engl J Med 340:115–26.
Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS, Windham GB, Ble A, Senin U, Ferrucci L. 2007. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 49:1841–50.
Sawicki W, Malejczyk J, Wróblewska J. 2015. Mechanizmy starzenia: uszkadzanie cząsteczek i zapalenie starcze. Gerontologia Polska 2:47–52.
Sayer AA, Kirkwood TBL. 2015. Grip strength and mortality: a biomarker of ageing? Lancet 386:226–7.
Schaap LA, Pluijm SM, Deeg DJ, Visser M. 2006. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119:526.e9–17.
Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M, Health ABC Study. 2009. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183–9.
Shay JW, Roninson IB. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919–33.
Shivappa N, Zucchetto A, Montella M, Serraino D, Steck SE, La Vecchia C, Hébert JR. 2015. Inflammatory potential of diet and risk of colorectal cancer: a case-control study from Italy. Br J Nutr 114:152–8.
Shivappa N, Hébert JR, Rosato V, Serraino D, La Vecchia C. 2016. Inflammatory potential of diet and risk of laryngeal cancer in a case control study from Italy. Cancer Causes Control 27:1027–34.
Sikora E. 2014. Starzenie i długowieczność. Postępy Biochemii 60(2):125-37.
Sikora E, Bielak-Zmijewska A, Mosieniak G. 2014. Cellular senescence in ageing, age-related disease and longevity. Curr Vasc Pharmacol 12:698–706.
Singh T, Newman AB. 2011. Inflammatory markers in population studies of aging. Ageing Res Rev10:319–29.
Tamakoshi K, Toyoshima H, Yatsuya H, Matsushita K, Okamura T, Hayakawa T, Okayama A, Ueshima H, NIPPON DATA90 Research Group. 2007. White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese--results from the NIPPON DATA90. Circ J 71:479–85.
Tatsukawa Y, Hsu WL, Yamada M, Cologne JB, Suzuki G, Yamamoto H, Yamane K, Akahoshi M, Fujiwara S, Kohno N. 2008. White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population. Hypertension Res 31:1391–7.
Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD, Kirkland JL. 2010. Fat tissue, aging, and cellular senescence. Aging Cell 9:667–84.
Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. 2013. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123:966–72.
Tietz NW, Shuey DF, Wekstein DR. 1992. Laboratory values in fit aging individuals – sexagenarians through centenarians. Clin Chem 38:1167–85.
Tiong AY, Brieger D. 2005. Inflammation and coronary artery disease. Am Heart J 150:11–8.
Vaiserman AM, Koliada AK, Marotta F. 2017. Gut microbiota: a player in aging and a target for anti-aging intervention. Ageing Res Rev 35:36–45.
Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. 2002. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455–61.
Wang H, Hu Y, Geng Y, Wu H, Chu YC, Liu R, Wei Y, Qiu Z. 2017. The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension. J Clin Hypertens 2017:1–6.
Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111–9.
Wheeler JG, Mussolino ME, Gillum RF, Danesh J. 2004. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 25:1287–92.
Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J. 2016. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab 23:303–14.
Wolański N. 2012. Rozwój biologiczny człowieka: podstawy auksologii, gerontologii i promocji zdrowia. Warszawa: Wydawnictwo Naukowe PWN.
Zacharski LR, Elveback LR, Kinman JW. 1971. Leukocyte counts in healthy adults. Am J Clin Pathol 56:148–50.
Zvaifler NJ. 1973. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265–336.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.


